Literature DB >> 18207279

Poor metabolic and blood pressure control in patients with diabetic retinopathy attending a tertiary ophthalmic hospital in Australia.

Gabriella Tikellis1, Shiqi Wang, Nathan Wong, Jie Jin Wang, C Alex Harper, Tien Y Wong.   

Abstract

AIM: To determine the adherence to recommended glycemic and blood pressure levels in patients with diabetic retinopathy (DR).
METHODS: A retrospective study in a tertiary eye clinic in Melbourne, Australia. Data pertaining to blood pressure (BP) and glycosylated hemoglobin (HbA1c) level were extracted from charts over a 3-month period. Optimal HbA1c was defined as levels <7%, and optimal BP control was defined as systolic/diastolic <130/80mmHg.
RESULTS: Of the 483 patients with DR in this study, only 54% (259/482) had a recorded HbA1c measurement. Of these, only 14% (36/259) had an optimal HbA1c level. Patients with longer diabetes duration were less likely to attain optimal HbA1c levels (age and gender adjusted odds ratio (OR) 0.23; 95% confidence intervals (CIs) 0.08-0.71 for diabetes duration 11-19 years, and OR 0.18%, 95% CI 0.06-0.58 for duration >20 years versus </=5 years). Optimal BP control was attained in only 18% (86/483) and was associated with younger age (OR 0.98; 95% CI 0.96-0.99, per year increase in age).
CONCLUSION: Adherence to clinical guidelines for glycemic and BP control in patients with DR was low, even in a well-developed healthcare system with free ophthalmic care access.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18207279     DOI: 10.1016/j.diabres.2007.11.017

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  5 in total

1.  Effects of receipt of guideline-recommended care on onset of diabetic retinopathy and its progression.

Authors:  Frank A Sloan; Daniel S Grossman; Paul P Lee
Journal:  Ophthalmology       Date:  2009-08       Impact factor: 12.079

2.  Comorbidity and glycemia control among patients with type 2 diabetes in primary care.

Authors:  Catherine Hudon; Martin Fortin; Marie-France Dubois; José Almirall
Journal:  Diabetes Metab Syndr Obes       Date:  2008-11-18       Impact factor: 3.168

Review 3.  Epidemiological issues in diabetic retinopathy.

Authors:  Peter H Scanlon; Stephen J Aldington; Irene M Stratton
Journal:  Middle East Afr J Ophthalmol       Date:  2013 Oct-Dec

4.  Diabetic retinopathy screening in incident diabetes mellitus type 2 in Germany between 2004 and 2013 - A prospective cohort study based on health claims data.

Authors:  Daniel Kreft; Myra B McGuinness; Gabriele Doblhammer; Robert P Finger
Journal:  PLoS One       Date:  2018-04-05       Impact factor: 3.240

5.  Validation of a New Diabetic Retinopathy Knowledge and Attitudes Questionnaire in People with Diabetic Retinopathy and Diabetic Macular Edema.

Authors:  Eva K Fenwick; Ryan E K Man; Alfred T L Gan; Amudha Aravindhan; Ching Siong Tey; Hasita Jian Tai Soon; Daniel S W Ting; San I Y Yeo; Shu Yen Lee; Gavin Tan; Tien Y Wong; Ecosse L Lamoureux
Journal:  Transl Vis Sci Technol       Date:  2020-09-30       Impact factor: 3.283

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.